The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphoma von Tward, Jonathan D., Wendland, Merideth M. M., Shrieve, Dennis C., Szabo, Aniko, Gaffney, David K.

Volltext

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913 von Chinnaiyan, Prakash, Won, Minhee, Wen, Patrick Y, Rojiani, Amyn M, Werner-Wasik, Maria, Shih, Helen A, Ashby, Lynn S, Michael Yu, Hsiang-Hsuan, Stieber, Volker W, Malone, Shawn C, Fiveash, John B, Mohile, Nimish A, Ahluwalia, Manmeet S, Wendland, Merideth M, Stella, Philip J, Kee, Andrew Y, Mehta, Minesh P

Volltext

NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma von Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Kenneth D., deGroot, John F., Pan, Edward, Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer M., Battiste, James D., Villano, John L., Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth M., Mehta, Minesh P.

Volltext

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825) von Wefel, Jeffrey S, Armstrong, Terri S, Pugh, Stephanie L, Gilbert, Mark R, Wendland, Merideth M, Brachman, David G, Roof, Kevin S, Brown, Paul D, Crocker, Ian R, Robins, H Ian, Hunter, Grant, Won, Minhee, Mehta, Minesh P

Volltext

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 von Patil, Nirav, Somasundaram, Eashwar, Waite, Kristin A., Lathia, Justin D., Machtay, Mitchell, Gilbert, Mark R., Connor, James R., Rubin, Joshua B., Berens, Michael E., Buerki, Robin A., Choi, Serah, Sloan, Andrew E., Penas-Prado, Marta, Ashby, Lynn S., Blumenthal, Deborah T., Werner-Wasik, Maria, Hunter, Grant K., Flickinger, John C., Wendland, Merideth M., Panet-Raymond, Valerie, Robins, H. Ian, Pugh, Stephanie L., Mehta, Minesh P., Barnholtz-Sloan, Jill S.

Volltext

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Gr... von Blumenthal, Deborah T, Won, Minhee, Mehta, Minesh P, Gilbert, Mark R, Brown, Paul D, Bokstein, Felix, Brachman, David G, Werner-Wasik, Maria, Hunter, Grant K, Valeinis, Egils, Hopkins, Kirsten, Souhami, Luis, Howard, Steven P, Lieberman, Frank S, Shrieve, Dennis C, Wendland, Merideth M, Robinson, Cliff G, Zhang, Peixin, Corn, Benjamin W

Volltext

Time interval to the development of breast carcinoma after treatment for Hodgkin disease von Wendland, Merideth M. M., Tsodikov, Alexander, Glenn, Martha J., Gaffney, David K.

Volltext

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy von Laack, Nadia N, Pugh, Stephanie L, Brown, Paul D, Fox, Sherry, Wefel, Jeffrey S, Meyers, Christina, Choucair, Ali, Khuntia, Deepak, Suh, John H, Roberge, David, Wendland, Merideth M, Bruner, Deborah

Volltext

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825 von Scheurer, Michael E, Zhou, Renke, Gilbert, Mark R, Bondy, Melissa L, Sulman, Erik P, Yuan, Ying, Liu, Yanhong, Vera, Elizabeth, Wendland, Merideth M, Youssef, Emad F, Stieber, Volker W, Komaki, Ritsuko R, Flickinger, John C, Kenyon, Lawrence C, Robins, H Ian, Hunter, Grant K, Crocker, Ian R, Chao, Samuel T, Pugh, Stephanie L, Armstrong, Terri S

Volltext

Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development von Kan, Peter, Liu, James K, Wendland, Merideth M, Shrieve, Dennis, Jensen, Randy L

Volltext

Novalis intensity-modulated radiosurgery: methods for pretreatment planning von Jensen, Randy L, Wendland, Merideth M, Chern, Shyh-Shi, Shrieve, Dennis C

Volltext

The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or r... von Wendland, Merideth M M, Asch, Julie D, Pulsipher, Michael A, Thomson, John W, Shrieve, Dennis C, Gaffney, David K

Volltext

The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell... von Wendland, Merideth M M, Smith, David C, Boucher, Kenneth M, Asch, Julie D, Pulsipher, Michael A, Thomson, John W, Shrieve, Dennis C, Gaffney, David K

Volltext

Extraneural metastatic medulloblastoma in an adult von WENDLAND, Merideth M, SHRIEVE, Dennis C, WATSON, Gordon A, CHIN, Steven S, BLUMENTHAL, Deborah T

Volltext

NRG/RTOG 1122: phase II double-blinded, placebo-controlled study of bevacizumab with/without trebananib in patients with recurrent glioblastoma or gliosarcoma von Lee, Eudocia Q, Zhang, Peixin, Wen, Patrick Y, Gerstner, Elizabeth R, Reardon, David A, Aldape, Kenneth D, deGroot, John F, Pan, Edward, Raizer, Jeffrey J, Kim, Lyndon J, Chmura, Steven J, Robins, H Ian, Connelly, Jennifer M, Battiste, James D, Villano, John L, Wagle, Naveed, Merrell, Ryan T, Wendland, Merideth M, Mehta, Minesh P

Volltext

RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma von Chinnaiyan, Prakash, MD, Won, Minhee, MA, Wen, Patrick Y., MD, Rojiani, Amyn M., MD, PhD, Wendland, Merideth, MD, Dipetrillo, Thomas A., MD, Corn, Benjamin W., MD, Mehta, Minesh P., MD, FASTRO

Volltext

A comparison of the cell lines used in meningioma research von Ragel, Brian T., MD, Couldwell, William T., MD, PhD, Gillespie, David L., PhD, Wendland, Merideth M., MD, Whang, Kum, MD, PhD, Jensen, Randy L., MD, PhD

Volltext

Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825 von Zhou, Renke, Scheurer, Michael E., Gilbert, Mark R., Bondy, Melissa, Sulman, Erik P., Yuan, Ying, Liu, Yanhong, Vera, Elizabeth, Wendland, Merideth M, Brachman, David, Bearden, James, McGovern, Susan Lynne, Wilson, Steven S., Judy, Kevin D., Robins, H. Ian, Hunter, Grant Kirton, Pugh, Stephanie L, Armstrong, Terri S.

Volltext

RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma von Chinnaiyan, Prakash, Won, Minhee, Wen, Patrick Y., Rojiani, Amyn, Wendland, Merideth M, DiPetrillo, Thomas A., Corn, Benjamin W., Mehta, Minesh P.

Volltext

Neurocognitive function (NCF) outcomes in patients with glioblastoma (GBM) enrolled in RTOG 0825 von Wefel, Jeffrey Scott, Pugh, Stephanie L., Armstrong, Terri S., Gilbert, Mark R., Won, Minhee, Wendland, Merideth M, Brachman, David, Komaki, Ritsuko, Crocker, Ian R., Robins, H. Ian, Lee, R. Jeffrey, Mehta, Minesh P.

Volltext